Celgene R&D is sustaining a deep and diverse pipeline of paradigm-changing innovation.
Celgene has R&D facilities strategically located around the United States and in Europe. Each location is uniquely equipped to its specialty.
Celgene Institute for Translational Research Europe (CITRE)
Multinational biopharmaceutical company Celgene, at the forefront of developing new treatments for cancer and inflammatory diseases, has now established the Celgene Institute for Translational Research Europe (CITRE) in Seville, Spain. CITRE is the company’s first dedicated R&D site outside the USA and provides a bridge between Celgene R&D and the European research community.
Celgene Avilomics research
Avilomics research, in Bedford, Massachusetts, US, provides Celgene with leadership in targeted covalent drugs. At Avilomics, we believe our targeted covalent drugs will substantially improve health outcomes through improved and durable efficacy over existing therapies, providing constant inhibition of disease processes.
Drug Discovery & Alliance Development
The Drug Discovery & Alliance Development centre in San Diego, California, is also our hub for epigenetics and intracellular signalling research and development. These platforms encompass the key functions required to generate a sustainable pipeline of paradigm-changing innovation.
Date of preparation: October 2017